ORAMED PHARMACEUTICALS INC. (ORMP) Net income 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$64.0MFY2025 · since FY2016: -$11.0M → $64.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $64.0M | +436.0% |
| FY2024 | -$19.1M | -474.6% |
| FY2023 | $5.1M | +113.9% |
| FY2022 | -$36.6M | -59.0% |
| FY2021 | -$23.0M | -99.7% |
| FY2020 | -$11.5M | +19.8% |
| FY2019 | -$14.4M | -12.8% |
| FY2018 | -$12.7M | -21.4% |
| FY2017 | -$10.5M | +4.4% |
| FY2016 | -$11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net marginORMP Gross profitORMP Gross marginORMP Operating incomeORMP Operating marginORMP Operating cash flowORMP Free cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Total liabilitiesORMP Shareholders’ equityORMP overview →